Kenji Nakayama
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Zebrafish Xenograft Model for Predicting Cisplatin Efficacy in Muscle-Invasive Bladder Cancer.
Journal: Cancer science
Published: July 18, 2025
Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy.
Journal: Cancer medicine
Published: April 30, 2022
Rapid and Convenient Quantitative Analysis of SARS-CoV-2 RNA in Serous Saliva with a Direct PCR Method.
Journal: Epidemiologia (Basel, Switzerland)
Published: May 28, 2021
A narrative review of urinary phospholipids: from biochemical aspect towards clinical application.
Journal: Translational andrology and urology
Published: May 10, 2021
Data processing on a comparative evaluation of the extraction and analysis procedures for urinary phospholipid and lysophospholipid using MALDI-TOF/MS.
Journal: Data in brief
Published: June 13, 2019
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies.
Journal: British journal of cancer
Published: May 02, 2019
Comparative evaluation of the extraction and analysis of urinary phospholipids and lysophospholipids using MALDI-TOF/MS.
Journal: Chemistry and physics of lipids
Published: February 20, 2019
The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer.
Journal: PloS one
Published: June 12, 2014
The expression profile of phosphatidylinositol in high spatial resolution imaging mass spectrometry as a potential biomarker for prostate cancer.
Journal: PloS one
Published: November 26, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026